Effect of leukotriene and thromboxane antagonist propranolol-induced bronchoconstriction

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 6, 1999, Pages 2100-2103

  Fujimura, Masaki ^a,b,c   Abo, Miki ^a,b   Kamio, Yumie ^a,b   Myou, Shigeharu ^a,b   Ishiura, Yoshihisa ^a,b   Hashimoto, Takuma ^a,b   Matsuda, Tamotsu ^a,b  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE RECEPTOR BLOCKING AGENT; PLACEBO; PRANLUKAST; PROPRANOLOL; SERATRODAST; THEOPHYLLINE; THROMBOXANE RECEPTOR BLOCKING AGENT;

ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0033457347     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.6.9902110     Document Type: Article

References (28)

1. McNeill, R. S. 1964. Effect of beta-adrenergic-blocking agent, propranolol, on asthmatics. Lancet 11:1101-1102.
2. Macdonald, A. G., C. G. Ingram, and R. S. McNeill. 1967. The effect of propranolol on airway resistance. Br. J. Anaesth. 39:919-926.
3. Zaid, G., and G. N. Beall. 1966. Bronchial response to beta-adrenergic blockade. N. Engl. J. Med. 275:580-584.
4. Townly, R. E., S. McGeady, and A. Bewtra. 1976. The effect of beta adrenergic blockade on bronchial sensitivity to acetyl-beta-methacholine in normal and allergic rhinitis subjects. J. Allergy Clin. Immunol. 57:358-366.
5. Ind, P. W., C. M. S. Dixon, R. W. Fuller, and P. J. Barnes. 1989. Anticholinergic blockade of beta-blocker-induced bronchoconstriction. Am. Rev. Respir. Dis. 139:1390-1394.
6. Terpstra, G. K., J. A. K. Raajimakers, and G. A. Wassink. 1981. Propranolol induced bronchoconstriction: a non specific side effect of beta-adrenergic blocking therapy. Eur. J. Pharmacol. 73:107-108.
7. Carpentiere, G., F. Castello, and S. Marino. 1991. Effect of oral terfenadine on the bronchoconstrictor response to inhaled propranolol and histamine in asthmatics. Curr. Ther. Res. 49:503-507.
8. 2 in propranolol-induced bronchoconstriction after allergic bronchoconstriction in guinea pigs. Am. J. Respir. Crit. Care Med. 149:1488-1493.
9. Fujimura, M., N. Songur, M. Tsujiura, K. Mizuhashi, S. Myou, and T. Matsuda. 1997. Role of leukotrienes in post-allergic propranolol-induced bronchoconstriction in guinea pigs. Clin. Exp. Allergy 27:1219-1226.
10. Taylor, I. K., K. M. O'Chaughnessy, R. W. Fuller, and C. T. Dollery. 1991. Effect of cysteinyl leukotriene receptor antagonist ICI-204,219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet 337:690-694.
11. Rasmussen, J. B., L. O. Eriksson, D. J. Margolskee, P. Tagari, V. C. Williams, and K. E. Andersson. 1992. Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma. J. Allergy Clin. Immunol. 90:193-201.
12. Manning, P. J., R. M. Watson, D. J. Margolskee, V. C. Williams, J. I. Schwartz, and P. M. O'Byrne. 1990. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene-D4 receptor antagonist. N. Engl. J. Med. 323:1736-1739.
13. Israel, E., E. F. Juniper, J. T. Callagham, P. N. Mathur, M. M. Morris, A. R. Dowell, G. G. Enas, F. E. Hargreave, and J. M. Drazen. 1989. Effect of a leukotriene antagonist, LY171883, on cold air-induced bronchoconstriction in asthmatics. Am. Rev. Respir. Dis. 149:1348-1353.
14. Yamamoto, H., M. Nagata, K. Kuramitsu, K. Tabe, H. Kiuchi, Y. Sakamoto, K. Yamamoto, and Y. Dohi. 1994. Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ONO-1078. Am. J. Respir. Crit. Care Med. 150:254-257.
15. Iwamono, I., C. Ra, T. Sato, H. Tomioka, and S. Yoshida. 1988. Thromboxane A2 production in allergen-induced immediate and late asthmatic responses: its possible role in inducing the late response. J. Asthma 25:117-124.
16. Hoshino, M., and Y. Fukushima. 1991. Effect of OKY-046 (thromboxane A2 synthetase inhibitor) on exercise-induced asthma. J. Asthma 28:19-29.
17. Beasley, R. C. W., R. L. Fetherstone, M. K. Church, P. Raffety, J. G. Vorley, A. Harris, C. Robinson, and S. T. Holgate. 1989. Effect of thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction. J. Appl. Physiol. 66:1685-1693.
18. Obase, Y., T. Shimoda, N. Matsuo, H. Matsuse, S. Asai, and S. Kohno. 1998. Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thrombuxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma. Chest 114:1028-1032.
19. Miyamoto, T., T. Takishima, S. Makino, T. Shida, M. Nakashima, and K. Hanaoka. 1993. Utility of a leukotriene C4, D4 and E4 antagonist, ONO-1078, on adult bronchial asthma in multi-center comparative double-blind clinical study with azelastine hydrochloride [in Japanese]. Rinsho-Iyaku 9(Suppl.):71-107.
20. Nakajima, S., T. Miyamoto, T. Takishima, T. Shida, S. Makino, S. Kishimoto, H. Nagano, I. Kimura, S. Suetsugu, and N. Ogawa. 1993. Dose finding study of AA-2414, a thromboxane A2 receptor antagonist, in adult patients with bronchial asthma: establishment of optimal dose in multi-center double-blind comparative study [in Japanese]. Rinsho-Iyaku 9(Suppl.):101-137.
21. Aizawa, H., H. Inoue, H. Matsumoto, M. Yoshida, S. Fukuyama, H. Koto, and H. Hara. 1998. Effects of thromboxane A2 antagonist on airway hyperresponsiveness, exhaled nitric oxide, and induced sputum eosinophils in asthmatics. Prostaglandins Leukot. Essent. Fatty Acids 59:185-190.
22. Wenzel, S. E., J. Y. Westcott, and G. L. Larsen. 1991. Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: relationship to the development of late asthmatic responses. J. Allergy Clin. Immunol. 87:540-548.
23. Wenzel, S. E., J. Y. Westcott, H. R. Smith, and G. L. Larsen. 1989. Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups: an alteration in the ratio of bronchoconstrictive to bronchoprotective mediators. Am. Rev. Respir. Dis. 139:450-457.
24. Crea, A. E. G., J. A. Nakhosteen, and T. H. Lec. 1992. Mediator concentrations in bronchoalveolar lavage fluid of patients with mild asymptomatic bronchial asthma. Eur. Respir. J. 5:190-195.
25. Impens, N., T. F. Reiss, J. A. Teahan, M. Desmet, T. H. Rossing, S. Thingo, J. Zhang, W. Schandevyl, R. Verbesselt, and A. G. Dupont. 1993. Acute bronchodilation with an intravenously administered leukotriene D4 antagonist, MK-679. Am. Rev. Respir. Dis. 147:1442-1446.
26. Fujimura, M., S. Sakamoto, Y. Kamio, and T. Matsuda. 1993. Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma. Respir. Med. 87:133-138.
27. 2 in bronchial hyperresponsiveness of asthma. Pulm. Pharmacol. 8:251-257.
28. Okayama, M., N. Yafuso, H. Nogami, Y. Lin, S. Horio, W. Hida, H. Inoue, and T. Takishima. 1987. A new method of inhalation challenge with propranolol: comparison with methacholine-induced bronchoconstriction and role of vagal nerve activity. J. Allergy Clin. Immunol. 80:291-299.